2Bocci V.Ozone as Janus:this controversial gas can be either toxic or medically useful[J].Modators Inflamm,2004,13(1):3-11.
3Wentworth P Jr,McDunn J E,Went worth A D,et al.Evidence for abtibody-catalyzod ozone formation in bacterial killing and inflammation[J].Science,2002,298 (5601):2195-2199.
4Babior B,Takeuehi C,Ruedi J.Investigating antibody-catalyzed generation by human neutrophils[J].Proc Natl Acad Sci,2003,100(6):3031-3034.
5Bocci V.Ozonization of blood for the therapy of viral diseases and immunodeficiencies[J].Med Hypotheses,1992,39 (1):30-34.
6Haensler R V.The use of ozone in medicine[M].4th.English edition:Odrei-publishers,2002:29-31.
7陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:717-718.
8Ciscione L G,Pisetsky D S.B Lymphocyte and systemic lupus erythematosus-[J].Curr Rheumatol Rep,2003,5 (4):264-269.
9Hagiwara E.Autoimmune diseases and Th1/Th2 balance[J].Ryumachi,2001041 (5):888-893.
1Horwitz DA, Gray JD, Ohtsuka K, et al. Role of NK cells and TGFbeta in the regulation of T-cell-dependent antibody production in health and autoimmune disease. Microbes Infec, 1999, 1:1305-1311.
2Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum,1992, 35: 630-640.
3Ohtsuka K, Gray JD, Stimmler MM, et al. Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus. J. Immunol, 1998, 160:2539-2545.
4Ohtsuka K, Gray JD, Quismorio FP Jr, et al. Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta. Lupus, 1999, 8:95-102.
5Scudla V, Horak P, Faltynek L, et al. The importance of determination of interleukin -10 in the blood of patients with systemic lupus erythematosus. Cas Lek Cesk, 1998, 137:44-47.
6Llorente L, Richaud-Patin Y, Garcia-Padilla C, et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administrationin systemic lupus erythematosus. Arthritis Rheum, 2000, 43: 1790-1800.
7Mohan IK, Das UN. Oxidant stress,anti-oxidants and essential fatty acids in systemic lupus erythematosus. Pmstaglandins Leukot Essent Fatty Acids, 1997, 56: 193.
8Bemaejo VT, Hidalgo CFJ. Antioxidants: the therapy of the future? Nutr-Hosp, 1997, 12: 108.
9Chan PH. Role of oxidants in ischemic damage. Stroke, 1996,27: 1124.
10Serban MG, Negru T. Antioxidant protection in collagen-vascular diseases.Rom-J-Intern-Med, 1998, 36: 245.
9Stimmler M M,Coletti P M,Quismorio E P,et al.Magnetic resonance imaging of the brain in neuropsythiatric systemic lupus erythematosus[J].Semin in Arthritis Rheum,1993,22(5):335-349.
10Koseda-Dragan M,Hebanowski M,Badzio-Jagiello H,et al.New diagnostic criteria for the neuropsychiatrie form of systemic lupus erythematosus[J].Psychiatr Pol,2000,34(6):993-1005.
